HS Pipeline Watch: Abbvie’s Lutikizumab Advances to Phase 3 in HS
Adults with moderate to severe hidradenitis suppurativa (HS) who had previously failed anti-TNF therapy showed higher response rates in Hidradenitis Suppurativa Clinical Response 50 (HiSCR) at week 16 when treated with lutikizumab (ABT-981) 300 mg every other week or 300 mg compared to patients who received placebo, according to results from a new Phase 2 study. […]
Study: DermTech’s Melanoma Test Can Rule Out the Cancer in Real-World Settings
DermTech, Inc.’s Melanoma Test (DMT) performed well in a real-world clinical setting, the Company reports. The test assesses pigmented skin lesions, moles or dark skin spots for melanoma. In particular, the PLA detects expression of the LINC00518 (LINC) and preferentially expressed antigen in melanoma (PRAME) genes using reverse transcription-polymerase chain reaction (RT-PCR). The Company introduced […]
Advances in Wound Healing: New High-Resolution Method May Help Analyze Skin Gene Expression After Burns
In findings that may help promote wound healing, scientists have developed a new high-resolution method to analyze skin gene expression post burns. The findings were published in the Journal of Burn Care & Research: official publication of the American Burn Association. Studying the timeline of gene activity after a burn is crucial for deciding optimal time for […]